<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 04 Oct 2021 08:00:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Greenlane Appoints Director Donald Hunter as Chairman of the Board</title>
   <link>http://www.streetinsider.com/Press+Releases/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html</guid>
   <pubDate>Mon, 04 Oct 2021 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GNLN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Greenlane Appoints Director Donald Hunter as Chairman of the Board</title>
   <link>http://www.streetinsider.com/Press+Releases/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html</guid>
   <pubDate>Mon, 04 Oct 2021 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GNLN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Greenlane Appoints Director Donald Hunter as Chairman of the Board</title>
   <link>http://www.streetinsider.com/Accesswire/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html</guid>
   <pubDate>Mon, 04 Oct 2021 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GNLN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Greenlane Appoints Director Donald Hunter as Chairman of the Board</title>
   <link>http://www.streetinsider.com/Accesswire/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/Greenlane+Appoints+Director+Donald+Hunter+as+Chairman+of+the+Board/19016418.html</guid>
   <pubDate>Mon, 04 Oct 2021 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GNLN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases</title>
   <link>http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Atalanta+Therapeutics+Launches+With+%24110+Million+to+Pioneer+RNAi+Therapeutics+for+Neurodegenerative+Diseases/17804358.html</guid>
   <pubDate>Mon, 11 Jan 2021 06:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24905830</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29331106</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32845002</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38484105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Form  4          JUNIPER PHARMACEUTICALS   For: Aug 14  Filed by: GERAGHTY JAMES A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GERAGHTY+JAMES+A/14519860.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GERAGHTY+JAMES+A/14519860.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GERAGHTY+JAMES+A/14519860.html</guid>
   <pubDate>Wed, 15 Aug 2018 16:33:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Form  4          JUNIPER PHARMACEUTICALS   For: Aug 14  Filed by: Csimma Cristina</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+Csimma+Cristina/14519829.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+Csimma+Cristina/14519829.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+Csimma+Cristina/14519829.html</guid>
   <pubDate>Wed, 15 Aug 2018 16:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Form  4          JUNIPER PHARMACEUTICALS   For: Aug 14  Filed by: GOOD JENNIFER L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GOOD+JENNIFER+L/14519794.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GOOD+JENNIFER+L/14519794.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GOOD+JENNIFER+L/14519794.html</guid>
   <pubDate>Wed, 15 Aug 2018 16:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Form  4          JUNIPER PHARMACEUTICALS   For: Aug 14  Filed by: GRAY MARY ANN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GRAY+MARY+ANN/14519785.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GRAY+MARY+ANN/14519785.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+GRAY+MARY+ANN/14519785.html</guid>
   <pubDate>Wed, 15 Aug 2018 16:27:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
  <item>
   <title>Form  4          JUNIPER PHARMACEUTICALS   For: Aug 14  Filed by: MERRIFIELD C ANN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+MERRIFIELD+C+ANN/14519765.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+MERRIFIELD+C+ANN/14519765.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++JUNIPER+PHARMACEUTICALS+++For%3A+Aug+14++Filed+by%3A+MERRIFIELD+C+ANN/14519765.html</guid>
   <pubDate>Wed, 15 Aug 2018 16:26:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">JNP</category>
   	  </item>
 </channel>
</rss>
